Diabetes Care, Vol 16, Issue 9 1254-1261, Copyright © 1993 by American Diabetes Association

ARTICLES

Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young

SS Fajans and MB Brown
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.

OBJECTIVE--To ascertain whether the effect of sulfonylureas on glucose-mediated insulin release persists for years to decades in patients with maturity-onset diabetes of the young. RESEARCH DESIGN AND METHODS--The effect of sulfonylurea treatment on glucose-induced insulin secretion was ascertained prospectively for up to 33 yr in 12 diabetic patients of the maturity-onset diabetes of the young RW pedigree, who are genetically homogeneous because they share DNA markers on chromosome 20q. In 7 of these patients, paired glucose tolerance tests, given while the patients were on and off sulfonylureas, were performed after 7-31 yr. RESULTS--Glucose-induced insulin secretion showed an average increase of 68% in diabetic patients who remained responsive to chlorpropamide after having been on and off the drug for decades. In most patients, however, glucose-induced insulin secretion declines over time (1-4%/yr). Some patients become unresponsive to sulfonylureas after 3-25 yr and then have very small or no increases in glucose-induced insulin secretion and require treatment with insulin to normalize fasting hyperglycemia. CONCLUSIONS--Increase in glucose-induced insulin secretion remains the most important mechanism of the action of sulfonylureas during long-term administration.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Johansen, J. Ek, H. B. Mortensen, O. Pedersen, and T. Hansen Half of Clinically Defined Maturity-Onset Diabetes of the Young Patients in Denmark Do Not Have Mutations in HNF4A, GCK, and TCF1 J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4607 - 4614. [Abstract] [Full Text] [PDF]

				J Weill, S Vanderbecken, and P Froguel Understanding the rising incidence of type 2 diabetes in adolescence Arch. Dis. Child., June 1, 2004; 89(6): 502 - 504. [Full Text] [PDF]

				S Bolkent, R Yanardag, O Karabulut-Bulan, and O Ozsoy-Sacan The morphological and biochemical effects of glibornuride on rat liver in experimental diabetes Human and Experimental Toxicology, May 1, 2004; 23(5): 257 - 264. [Abstract] [PDF]

				S. S. Fajans, G. I. Bell, and K. S. Polonsky Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young N. Engl. J. Med., September 27, 2001; 345(13): 971 - 980. [Full Text] [PDF]

				C. Pihoker, C. R. Scott, S. Y. Lensing, M. Michaeleen Cradock, and J. Smith Non-Insulin Dependent Diabetes Mellitus in African-American Youths of Arkansas Clinical Pediatrics, February 1, 1998; 37(2): 97 - 102. [Abstract] [PDF]

				C. R. Scott, J. M. Smith, M. M. Cradock, and C. Pihoker Characteristics of Youth-onset Noninsulin-dependent Diabetes Mellitus and Insulin-dependent Diabetes Mellitus at Diagnosis Pediatrics, July 1, 1997; 100(1): 84 - 91. [Abstract] [Full Text] [PDF]